High pretreatment plasma Epstein‐Barr virus (EBV) DNA level is a poor prognostic marker in HIV‐associated, EBV‐negative diffuse large B‐cell lymphoma in Malawi

Plasma Epstein‐Barr virus (EBV) DNA measurement has established prognostic utility in EBV‐driven lymphomas, where it serves as a circulating tumor DNA marker. The value of plasma EBV measurement may be amplified in sub‐Saharan Africa (SSA), where advanced imaging and molecular technologies for risk...

Descripción completa

Detalles Bibliográficos
Autores principales: Montgomery, Nathan D., Randall, Cara, Painschab, Matthew, Seguin, Ryan, Kaimila, Bongani, Kasonkanji, Edwards, Zuze, Takondwa, Krysiak, Robert, Sanders, Marcia K., Elliott, Avian, Miller, Melissa B., Kampani, Coxcilly, Chimzimu, Fred, Mulenga, Maurice, Damania, Blossom, Tomoka, Tamiwe, Fedoriw, Yuri, Dittmer, Dirk P., Gopal, Satish
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6970037/
https://www.ncbi.nlm.nih.gov/pubmed/31782984
http://dx.doi.org/10.1002/cam4.2710

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6970037/
https://www.ncbi.nlm.nih.gov/pubmed/31782984
http://dx.doi.org/10.1002/cam4.2710

Ejemplares similares